世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

αマンノシドーシス治療薬の世界市場の洞察と2028年までの予測

αマンノシドーシス治療薬の世界市場の洞察と2028年までの予測


Global Alpha Mannosidosis Treatments Market Insights and Forecast to 2028

市場分析と洞察。アルファマンノシドーシス治療薬の世界市場 アルファマンノシドーシス治療薬の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間、年率... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2022年1月14日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場分析と洞察。アルファマンノシドーシス治療薬の世界市場
アルファマンノシドーシス治療薬の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間、年率％で推移すると考えられます。
この健康危機による経済的変化を十分に考慮し、2021年にはαマンノシドーシス治療薬の世界市場の％を占めていた骨髄移植（BMT）は、ポストCOVID-19の期間に改訂された％CAGRで成長し、2028年には100万米ドルになると予測されています。一方、「病院」セグメントは、この予測期間中、年率％で変化しています。
中国のαマンノシドーシス治療薬の市場規模は2021年に百万米ドル、北米と欧州のαマンノシドーシス治療薬の市場規模はそれぞれ百万米ドルと百万米ドルとなっています。2021年の市場規模は、北米が %、中国が %、欧州が % となっており、2028年には中国が % に達すると予測されています。アジアでは、日本、韓国、東南アジアが注目されており、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州のαマンノシドーシス治療薬市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のAlpha Mannosidosis Treatments市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、αマンノシドーシス治療薬の世界市場全体の規模（売上高）など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、世界のAlpha Mannosidosis Treatments市場において、競合他社よりも優位に立ち、永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のAlpha Mannosidosis Treatments市場を詳細に調査するために、独自の業界最高の調査・分析手法を用いています。
世界のαマンノシドーシス治療薬のスコープと市場規模
αマンノシドーシス治療薬市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のAlpha Mannosidosis Treatments市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。
タイプ別セグメント
骨髄移植(BMT)
酵素補充療法(ERT)
アプリケーション別セグメント
病院
専門クリニック
会社別
Chiesi Farmaceutici
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Mannosidosis Treatments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bone Marrow Transplant (BMT)
1.2.3 Enzyme Replacement Therapy (ERT)
1.3 Market by Application
1.3.1 Global Alpha Mannosidosis Treatments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha Mannosidosis Treatments Market Perspective (2017-2028)
2.2 Alpha Mannosidosis Treatments Growth Trends by Region
2.2.1 Alpha Mannosidosis Treatments Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alpha Mannosidosis Treatments Historic Market Size by Region (2017-2022)
2.2.3 Alpha Mannosidosis Treatments Forecasted Market Size by Region (2023-2028)
2.3 Alpha Mannosidosis Treatments Market Dynamics
2.3.1 Alpha Mannosidosis Treatments Industry Trends
2.3.2 Alpha Mannosidosis Treatments Market Drivers
2.3.3 Alpha Mannosidosis Treatments Market Challenges
2.3.4 Alpha Mannosidosis Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha Mannosidosis Treatments Players by Revenue
3.1.1 Global Top Alpha Mannosidosis Treatments Players by Revenue (2017-2022)
3.1.2 Global Alpha Mannosidosis Treatments Revenue Market Share by Players (2017-2022)
3.2 Global Alpha Mannosidosis Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha Mannosidosis Treatments Revenue
3.4 Global Alpha Mannosidosis Treatments Market Concentration Ratio
3.4.1 Global Alpha Mannosidosis Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Mannosidosis Treatments Revenue in 2021
3.5 Alpha Mannosidosis Treatments Key Players Head office and Area Served
3.6 Key Players Alpha Mannosidosis Treatments Product Solution and Service
3.7 Date of Enter into Alpha Mannosidosis Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha Mannosidosis Treatments Breakdown Data by Type
4.1 Global Alpha Mannosidosis Treatments Historic Market Size by Type (2017-2022)
4.2 Global Alpha Mannosidosis Treatments Forecasted Market Size by Type (2023-2028)
5 Alpha Mannosidosis Treatments Breakdown Data by Application
5.1 Global Alpha Mannosidosis Treatments Historic Market Size by Application (2017-2022)
5.2 Global Alpha Mannosidosis Treatments Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alpha Mannosidosis Treatments Market Size (2017-2028)
6.2 North America Alpha Mannosidosis Treatments Market Size by Type
6.2.1 North America Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
6.2.2 North America Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
6.2.3 North America Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
6.3 North America Alpha Mannosidosis Treatments Market Size by Application
6.3.1 North America Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
6.3.2 North America Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
6.3.3 North America Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
6.4 North America Alpha Mannosidosis Treatments Market Size by Country
6.4.1 North America Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
6.4.2 North America Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Alpha Mannosidosis Treatments Market Size (2017-2028)
7.2 Europe Alpha Mannosidosis Treatments Market Size by Type
7.2.1 Europe Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
7.2.2 Europe Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
7.2.3 Europe Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
7.3 Europe Alpha Mannosidosis Treatments Market Size by Application
7.3.1 Europe Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
7.3.2 Europe Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
7.3.3 Europe Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
7.4 Europe Alpha Mannosidosis Treatments Market Size by Country
7.4.1 Europe Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
7.4.2 Europe Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size (2017-2028)
8.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Type
8.2.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
8.3 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Application
8.3.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
8.4 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Region
8.4.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alpha Mannosidosis Treatments Market Size (2017-2028)
9.2 Latin America Alpha Mannosidosis Treatments Market Size by Type
9.2.1 Latin America Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
9.2.2 Latin America Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
9.2.3 Latin America Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
9.3 Latin America Alpha Mannosidosis Treatments Market Size by Application
9.3.1 Latin America Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
9.3.2 Latin America Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
9.3.3 Latin America Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
9.4 Latin America Alpha Mannosidosis Treatments Market Size by Country
9.4.1 Latin America Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
9.4.2 Latin America Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size (2017-2028)
10.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Type
10.2.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
10.3 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Application
10.3.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
10.4 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Country
10.4.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Details
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Alpha Mannosidosis Treatments Introduction
11.1.4 Chiesi Farmaceutici Revenue in Alpha Mannosidosis Treatments Business (2017-2022)
11.1.5 Chiesi Farmaceutici Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Alpha Mannosidosis Treatments Market
The global Alpha Mannosidosis Treatments market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Bone Marrow Transplant (BMT) accounting for % of the Alpha Mannosidosis Treatments global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Alpha Mannosidosis Treatments market size is valued at US$ million in 2021, while the North America and Europe Alpha Mannosidosis Treatments are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Alpha Mannosidosis Treatments landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alpha Mannosidosis Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alpha Mannosidosis Treatments market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alpha Mannosidosis Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alpha Mannosidosis Treatments market.
Global Alpha Mannosidosis Treatments Scope and Market Size
Alpha Mannosidosis Treatments market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Alpha Mannosidosis Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bone Marrow Transplant (BMT)
Enzyme Replacement Therapy (ERT)
Segment by Application
Hospitals
Specialty Clinic
By Company
Chiesi Farmaceutici
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Mannosidosis Treatments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bone Marrow Transplant (BMT)
1.2.3 Enzyme Replacement Therapy (ERT)
1.3 Market by Application
1.3.1 Global Alpha Mannosidosis Treatments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha Mannosidosis Treatments Market Perspective (2017-2028)
2.2 Alpha Mannosidosis Treatments Growth Trends by Region
2.2.1 Alpha Mannosidosis Treatments Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alpha Mannosidosis Treatments Historic Market Size by Region (2017-2022)
2.2.3 Alpha Mannosidosis Treatments Forecasted Market Size by Region (2023-2028)
2.3 Alpha Mannosidosis Treatments Market Dynamics
2.3.1 Alpha Mannosidosis Treatments Industry Trends
2.3.2 Alpha Mannosidosis Treatments Market Drivers
2.3.3 Alpha Mannosidosis Treatments Market Challenges
2.3.4 Alpha Mannosidosis Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha Mannosidosis Treatments Players by Revenue
3.1.1 Global Top Alpha Mannosidosis Treatments Players by Revenue (2017-2022)
3.1.2 Global Alpha Mannosidosis Treatments Revenue Market Share by Players (2017-2022)
3.2 Global Alpha Mannosidosis Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha Mannosidosis Treatments Revenue
3.4 Global Alpha Mannosidosis Treatments Market Concentration Ratio
3.4.1 Global Alpha Mannosidosis Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Mannosidosis Treatments Revenue in 2021
3.5 Alpha Mannosidosis Treatments Key Players Head office and Area Served
3.6 Key Players Alpha Mannosidosis Treatments Product Solution and Service
3.7 Date of Enter into Alpha Mannosidosis Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha Mannosidosis Treatments Breakdown Data by Type
4.1 Global Alpha Mannosidosis Treatments Historic Market Size by Type (2017-2022)
4.2 Global Alpha Mannosidosis Treatments Forecasted Market Size by Type (2023-2028)
5 Alpha Mannosidosis Treatments Breakdown Data by Application
5.1 Global Alpha Mannosidosis Treatments Historic Market Size by Application (2017-2022)
5.2 Global Alpha Mannosidosis Treatments Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alpha Mannosidosis Treatments Market Size (2017-2028)
6.2 North America Alpha Mannosidosis Treatments Market Size by Type
6.2.1 North America Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
6.2.2 North America Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
6.2.3 North America Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
6.3 North America Alpha Mannosidosis Treatments Market Size by Application
6.3.1 North America Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
6.3.2 North America Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
6.3.3 North America Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
6.4 North America Alpha Mannosidosis Treatments Market Size by Country
6.4.1 North America Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
6.4.2 North America Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Alpha Mannosidosis Treatments Market Size (2017-2028)
7.2 Europe Alpha Mannosidosis Treatments Market Size by Type
7.2.1 Europe Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
7.2.2 Europe Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
7.2.3 Europe Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
7.3 Europe Alpha Mannosidosis Treatments Market Size by Application
7.3.1 Europe Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
7.3.2 Europe Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
7.3.3 Europe Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
7.4 Europe Alpha Mannosidosis Treatments Market Size by Country
7.4.1 Europe Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
7.4.2 Europe Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size (2017-2028)
8.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Type
8.2.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
8.3 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Application
8.3.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
8.4 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Region
8.4.1 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Alpha Mannosidosis Treatments Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alpha Mannosidosis Treatments Market Size (2017-2028)
9.2 Latin America Alpha Mannosidosis Treatments Market Size by Type
9.2.1 Latin America Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
9.2.2 Latin America Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
9.2.3 Latin America Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
9.3 Latin America Alpha Mannosidosis Treatments Market Size by Application
9.3.1 Latin America Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
9.3.2 Latin America Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
9.3.3 Latin America Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
9.4 Latin America Alpha Mannosidosis Treatments Market Size by Country
9.4.1 Latin America Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
9.4.2 Latin America Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size (2017-2028)
10.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Type
10.2.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Alpha Mannosidosis Treatments Market Share by Type (2017-2028)
10.3 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Application
10.3.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Alpha Mannosidosis Treatments Market Share by Application (2017-2028)
10.4 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Country
10.4.1 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Alpha Mannosidosis Treatments Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Details
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Alpha Mannosidosis Treatments Introduction
11.1.4 Chiesi Farmaceutici Revenue in Alpha Mannosidosis Treatments Business (2017-2022)
11.1.5 Chiesi Farmaceutici Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:571 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68a805fa34b2e0_16717164() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68a805fa26a288_46622063() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 571